Finance

Lists
1S1:FRA
Viridian Therapeutics Inc
€19.70
+0.51%
(+0.10) 1D
Sep 4, 8:09:05 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1S1...
Open
€19.70
High
€19.70
Low
€19.70
Mkt. cap
2.58B
Avg. vol.
17.00
Volume
0.00
52-wk high
€28.58
52-wk low
€11.20
No. of employees
252
Open
€19.70
High
€19.70
Low
€19.70
Mkt. cap
2.58B
Avg. vol.
17.00
Volume
0.00
52-wk high
€28.58
52-wk low
€11.20
No. of employees
252
About Viridian Therapeutics Inc
CEO-
Employees252
Founded2010
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
70.57M
132.00K
141.00K
284.00K
Cost of goods sold
86.26M
92.71M
77.63M
71.58M
Cost of revenue
86.26M
92.71M
77.63M
71.58M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.32M
33.67M
38.68M
54.98M
Operating expense
24.32M
33.67M
38.68M
54.98M
Total operating expenses
110.58M
126.38M
116.31M
126.55M
Operating income
-40.01M
-126.25M
-116.17M
-126.27M
Other non operating income
453.00K
-2.12M
6.86M
-1.03M
EBT including unusual items
-34.60M
-120.36M
-104.90M
-127.12M
EBT excluding unusual items
-34.60M
-123.86M
-104.90M
-127.12M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-34.60M
-120.36M
-104.90M
-127.12M
Net profit margin
-49.03%
-91,178.03%
-74,397.87%
-44,760.21%
Earnings per share
-0.34
-1.08
-0.90
-1.05
Interest and investment income
5.52M
7.79M
7.87M
8.49M
Interest expense
-560.00K
-3.28M
-3.46M
-8.31M
Net interest expenses
4.96M
4.51M
4.41M
183.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-39.90M
-126.13M
-116.05M
-126.15M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps